THE DEVELOPMENT OF ANTI-INTERLEUKIN-2 ANTIBODIES IN PATIENTS TREATED WITH RECOMBINANT HUMAN INTERLEUKIN-2 (IL-2)

被引:37
作者
ALLEGRETTA, M [1 ]
ATKINS, MB [1 ]
DEMPSEY, RA [1 ]
BRADLEY, EC [1 ]
KONRAD, MW [1 ]
CHILDS, A [1 ]
WOLFE, SN [1 ]
MIER, JW [1 ]
机构
[1] CETUS CORP,EMERYVILLE,CA 94608
关键词
D O I
10.1007/BF00915254
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:481 / 490
页数:10
相关论文
共 27 条
[1]  
Atkins MB, J CLIN ONCOL
[2]  
DEMPSEY RA, 1982, J IMMUNOL, V129, P2504
[3]   CLONED CELL-LINES WITH NATURAL-KILLER ACTIVITY - SPECIFICITY, FUNCTION, AND CELL-SURFACE MARKERS [J].
DENNERT, G ;
YOGEESWARAN, G ;
YAMAGATA, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 153 (03) :545-556
[4]  
GILLIS S, 1978, J IMMUNOL, V120, P2027
[5]   IDENTIFICATION OF TISSUE-SPECIFIC NUCLEAR ANTIGENS TRANSFERRED TO NITROCELLULOSE FROM POLYACRYLAMIDE GELS [J].
GLASS, WF ;
BRIGGS, RC ;
HNILICA, LS .
SCIENCE, 1981, 211 (4477) :70-72
[6]   ANTIBODIES TO INTERLEUKIN-2 - EFFECTS ON IMMUNE-RESPONSES INVITRO AND INVIVO [J].
GRANELLIPIPERNO, A ;
ANDRUS, L ;
REICH, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (03) :738-750
[7]   LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON .3. EVIDENCE THAT IL-2 IS SUFFICIENT FOR DIRECT ACTIVATION OF PERIPHERAL-BLOOD LYMPHOCYTES INTO LYMPHOKINE-ACTIVATED KILLER CELLS [J].
GRIMM, EA ;
ROBB, RJ ;
ROTH, JA ;
NECKERS, LM ;
LACHMAN, LB ;
WILSON, DJ ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (04) :1356-1361
[8]   LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].
GRIMM, EA ;
MAZUMDER, A ;
ZHANG, HZ ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) :1823-1841
[9]   LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON .2. PRECURSOR PHENOTYPE IS SEROLOGICALLY DISTINCT FROM PERIPHERAL LYMPHOCYTES-T, MEMORY CYTO-TOXIC THYMUS-DERIVED LYMPHOCYTES, AND NATURAL-KILLER CELLS [J].
GRIMM, EA ;
RAMSEY, KM ;
MAZUMDER, A ;
WILSON, DJ ;
DJEU, JY ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (03) :884-897
[10]   RECOMBINANT LEUKOCYTE-A INTERFERON - PHARMACOKINETICS, SINGLE-DOSE TOLERANCE, AND BIOLOGIC EFFECTS IN CANCER-PATIENTS [J].
GUTTERMAN, JU ;
FINE, S ;
QUESADA, J ;
HORNING, SJ ;
LEVINE, JF ;
ALEXANIAN, R ;
BERNHARDT, L ;
KRAMER, M ;
SPIEGEL, H ;
COLBURN, W ;
TROWN, P ;
MERIGAN, T ;
DZIEWANOWSKI, Z .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (05) :549-556